Click on this link to hear an episode of Accad and Koka with an interview of Dr. Peter McCullough including an engaging review of early outpatient treatment of COVID-19, levels of evidence, inpatient treatment, and clinical outcomes across the globe in patients receiving care for COVID-19. The interview touches on controversial figures such as the […]
Author: publisher
COVID-19 Will Cost the World $24.4 Trillion, And Recovery Will Be Very Uneven
“The International Monetary Fund reckons economic recovery for many countries will take a long time” By Lukas Rühli, courtesy of Avenir Suisse Almost eight months have passed since Avenir Suisse on March 9 discussed the IMF’s regular GDP forecasts and calculated the enormous economic downswings suffered by various countries since the start of the […]
Europe’s banking union should learn the right lessons from the US
By Anna Gelpern and Nicolas Véron, courtesy of the Bruegel Institute In revived discussions on European banking union, some have suggested a new regime to deal with failing banks, alongside existing ones, drawn from parts of the United States’ bank resolution framework. This fragmented approach could be counterproductive. Europe should adopt a unitary regime, […]
With tax revenues rising, states do NOT need more federal aid
“State and Local Tax Revenues Are Rising” By Chris Edwards, courtesy of the Cato Institute A Wall Street Journal news piece this week was titled “U.S. States Face Biggest Cash Crisis Since the Great Depression.” But new data from the U.S. Bureau of Economic Analysis suggest that the Journal headline and story were needless scaremongering. The BEA data […]
Massive Stimulus Proposal Is Another Bad Idea
“Another Bad Idea” By Jack Salmon, courtesy of the Mercatus Center There is a disconnect between proposed stimulus spending and improving economic conditions. Policymakers have been quarreling over the content and size of a proposed new stimulus spending bill for five consecutive months now. In the latest round of discussions, Democratic lawmakers called for […]
Washington Beyond the Headlines: Norquist Demolishes Price Controls (Again)
By Andy Blom, TES Washington Editor Fall suddenly hit the East Coast with colder temperatures, early nightfall, leaves all over the ground and dark skies (with or without rain) during the day. Just the time to stay inside and curl up with a hot beverage and some good policy. Luckily, we have just the […]
Trump’s Blue Collar Tax Reform Boom Restored — but Biden and Harris want only repeal
By Lewis K. Uhler and Peter J. Ferrara, National Tax Limitation Foundation Tax Reform in the form of the 2017 Tax Cuts and Jobs Act is supporting booming economic growth to this day. Just reported third quarter numbers set an all time record: 33.1% growth over the second quarter, for a 7.4% annualized rate. […]
No Holy Grail on Drug Prices in Importation
By James Edwards The Trump administration’s drug importation rule takes another step in seeking the holy grail of lower drug costs. It’s a noble quest destined for failure. Like the recent order pegging Medicare pharmaceutical payments to those of foreign government-run health systems, drug importation too will backfire. All Americans want foreign […]
The Right’s America As Good vs. the Left’s America as Evil
By Ralph Benko The 2020 election is generating an important, overdue, national conversation. Is America not merely great but, more important, fundamentally good? And why. President Trump believes in America, which has been very good to him, the Good. So, of course, does Vice President Biden. Mr. Biden, however, may prove susceptible to pressure from […]
How to hijack a randomized trial in a few easy steps
By Erik Sass, TES Editor-in-Chief As controversy continues to rage about the efficacy of hydroxychloroquine and other drugs against COVID-19, regulators and scientific authorities in the U.S. and abroad have consistently held up randomized controlled trials (RCTs) as the “gold standard” of drug efficacy research – but what if there was actually a way […]